Literature DB >> 16379002

Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.

Bernhard Mani1, Claudia Baltzer, Noelia Valle, José M Almendral, Christoph Kempf, Carlos Ros.   

Abstract

Minute virus of mice (MVM) enters the host cell via receptor-mediated endocytosis. Although endosomal processing is required, its role remains uncertain. In particular, the effect of low endosomal pH on capsid configuration and nuclear delivery of the viral genome is unclear. We have followed the progression and structural transitions of DNA full-virus capsids (FC) and empty capsids (EC) containing the VP1 and VP2 structural proteins and of VP2-only virus-like particles (VLP) during the endosomal trafficking. Three capsid rearrangements were detected in FC: externalization of the VP1 N-terminal sequence (N-VP1), cleavage of the exposed VP2 N-terminal sequence (N-VP2), and uncoating of the full-length genome. All three capsid modifications occurred simultaneously, starting as early as 30 min after internalization, and all of them were blocked by raising the endosomal pH. In particles lacking viral single-stranded DNA (EC and VLP), the N-VP2 was not exposed and thus it was not cleaved. However, the EC did externalize N-VP1 with kinetics similar to those of FC. The bulk of all the incoming particles (FC, EC, and VLP) accumulated in lysosomes without signs of lysosomal membrane destabilization. Inside lysosomes, capsid degradation was not detected, although the uncoated DNA of FC was slowly degraded. Interestingly, at any time postinfection, the amount of structural proteins of the incoming virions accumulating in the nuclear fraction was negligible. These results indicate that during the early endosomal trafficking, the MVM particles are structurally modified by low-pH-dependent mechanisms. Regardless of the structural transitions and protein composition, the majority of the entering viral particles and genomes end in lysosomes, limiting the efficiency of MVM nuclear translocation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16379002      PMCID: PMC1346861          DOI: 10.1128/JVI.80.2.1015-1024.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts.

Authors:  J Hansen; K Qing; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 2.  Picornavirus-receptor interactions.

Authors:  Michael G Rossmann; Yongning He; Richard J Kuhn
Journal:  Trends Microbiol       Date:  2002-07       Impact factor: 17.079

3.  A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini.

Authors:  Stephanie Kronenberg; Bettina Böttcher; Claus W von der Lieth; Svenja Bleker; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  The parvovirus MVM: a comparison of heavy and light particle infectivity and their density conversion in vitro.

Authors:  G M Clinton; M Hayashi
Journal:  Virology       Date:  1976-10-01       Impact factor: 3.616

5.  Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking.

Authors:  J S Parker; C R Parrish
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport.

Authors:  M Vihinen-Ranta; W Yuan; C R Parrish
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction.

Authors:  Bernd Hauck; Wei Zhao; Katherine High; Weidong Xiao
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.

Authors:  Mari-Paz Rubio; Alberto López-Bueno; José M Almendral
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Nuclear export of the nonenveloped parvovirus virion is directed by an unordered protein signal exposed on the capsid surface.

Authors:  Beatriz Maroto; Noelia Valle; Rainer Saffrich; José M Almendral
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  The trypsin-sensitive RVER domain in the capsid proteins of minute virus of mice is required for efficient cell binding and viral infection but not for proteolytic processing in vivo.

Authors:  G E Tullis; L R Burger; D J Pintel
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

View more
  51 in total

1.  Mutations at the base of the icosahedral five-fold cylinders of minute virus of mice induce 3'-to-5' genome uncoating and critically impair entry functions.

Authors:  Susan F Cotmore; Peter Tattersall
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 2.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

3.  The structure and host entry of an invertebrate parvovirus.

Authors:  Geng Meng; Xinzheng Zhang; Pavel Plevka; Qian Yu; Peter Tijssen; Michael G Rossmann
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

4.  Detecting small changes and additional peptides in the canine parvovirus capsid structure.

Authors:  Christian D S Nelson; Eveliina Minkkinen; Magnus Bergkvist; Karin Hoelzer; Mathew Fisher; Brian Bothner; Colin R Parrish
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

5.  Mapping Antigenic Epitopes on the Human Bocavirus Capsid.

Authors:  Shweta Kailasan; Jamie Garrison; Maria Ilyas; Paul Chipman; Robert McKenna; Kalle Kantola; Maria Söderlund-Venermo; Indrė Kučinskaitė-Kodzė; Aurelija Žvirblienė; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

6.  Visualization of the externalized VP2 N termini of infectious human parvovirus B19.

Authors:  Bärbel Kaufmann; Paul R Chipman; Victor A Kostyuchenko; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

7.  Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells.

Authors:  Nicholas W Keiser; Ziying Yan; Yulong Zhang; Diana C M Lei-Butters; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2011-06-28       Impact factor: 5.695

8.  Autonomous parvoviruses neither stimulate nor are inhibited by the type I interferon response in human normal or cancer cells.

Authors:  Justin C Paglino; Wells Andres; Anthony N van den Pol
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

9.  Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.

Authors:  Claudia Bönsch; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.

Authors:  Claudia Bönsch; Christoph Kempf; Ivo Mueller; Laurens Manning; Moses Laman; Timothy M E Davis; Carlos Ros
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.